Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 36, 1580-1584, May 1, 1976]
© 1976 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Merski, J. A.
Right arrow Articles by Busch, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Merski, J. A.
Right arrow Articles by Busch, H.

Effects of Adriamycin on Ultrastructure of Nucleoli in the Heart and Liver Cells of the Rat1

Jerome A. Merski2, Ierachmiel Daskal and Harris Busch

Electron Microscopy Laboratory, Department of Pharmacology, Baylor College of Medicine, Houston, Texas 77025

Ultrastructural studies of the effects of adriamycin on liver and cardiac cell nucleoli of the rat showed that nucleolar segregation occurred within 1 hr after an i.v. injection of a 40-mg/kg dose.

Between 3 and 27 hr after this single dose, liver cell nucleoli progressively reverted to a normal ultrastructure. Nucleoli of rat myocardial cells did not recover but underwent further fragmentation, segregation, and conversion to ring-shaped structures. The ultrastructural alterations of myocardial cell nucleoli may represent an important aspect of adriamycin toxicity.

1 These studies were supported by the Cancer Research Center Grant CA-10893, P.5, awarded by the National Cancer Institute, Department of Health, Education and Welfare; the Davidson Fund; and a generous gift from Mrs. Jack Hutchins.

2 Predoctoral Fellow supported by the USPHS Grant CA-05154.

Received 11/10/75. Accepted 1/16/76.




This article has been cited by other articles:


Home page
Toxicol PatholHome page
L. Chaiswing, M. P. Cole, D. K. St. Clair, W. Ittarat, L. I. Szweda, and T. D. Oberley
Oxidative Damage Precedes Nitrative Damage in Adriamycin-Induced Cardiac Mitochondrial Injury
Toxicol Pathol, August 1, 2004; 32(5): 536 - 547.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
T. Zima, V. Tesar, R. Sherwood, A. Sood, L.-C. Au, P. J. Richardson, and V. R. Preedy
Acute Dosage With Dexrazoxane, but not Doxorubicin, Is Associated With Increased Rates of Hepatic Protein Synthesis in vivo
Toxicol Pathol, October 1, 2001; 29(6): 591 - 599.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1976 by the American Association for Cancer Research.